Brawn Biotech Ltd. Appoints Secretarial Auditor and Internal Auditors
Brawn Biotech Ltd. announced on March 25, 2026, that its Board of Directors approved the appointments of Mr. Viney and M/s Sahil Pasricha & Associates. The decisions were made at a board meeting held on March 25, 2026, which commenced at 11:00 A.M. and concluded at 11:30 A.M.Mr. Viney, a Practicing Company Secretary (CoP No. 28263), has been appointed as the Secretarial Auditor for the financial year 2025-26. He is an Associate Member of the Institute of Company Secretaries of India (ICSI) and possesses expertise in corporate, securities, and compliance management.
M/s Sahil Pasricha & Associates (FRN: 026379N), a Chartered Accountant firm, has been appointed as the Internal Auditors for the financial year 2025-26. The firm offers a range of services, including audit, taxation, and consultancy.
Annexure A: Details of Secretarial Auditor Appointment
| Details of events | Particulars |
|---|---|
| Reason for change | Appointment of Mr. Viney as the Secretarial Auditor of the Company. |
| Date of appointment & term | March 25, 2026 (Tenure - For FY 2025-26) |
| Brief Profile | Mr. Viney is a Practicing Company Secretary with expertise in corporate laws, securities laws, and compliance management, including LODR, PIT Regulations, and corporate governance advisory. |
| Disclosure of relationships between directors | Not Applicable |
Annexure B: Details of Internal Auditors Appointment
| Details of events | Particulars |
|---|---|
| Reason for change | Appointment of M/s Sahil Pasricha & Associates as Internal Auditors of the Company. |
| Date of appointment & term | March 25, 2026 (Tenure - For FY 2025-26) |
| Brief Profile | M/s Sahil Pasricha & Associates is a Chartered Accountant firm offering services including audit, income tax, GST audit, and consultancy. |
| Disclosure of relationships between directors | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.